JPMORGAN CHASE & CO - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 39 filers reported holding LOGICBIO THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
24
-93.0%
0.00%
Q4 2021$1,000
-99.6%
344
-99.4%
0.00%
Q2 2021$254,000
-85.6%
57,286
-76.3%
0.00%
Q1 2021$1,760,000
-19.4%
241,799
-15.5%
0.00%
Q4 2020$2,183,000
-24.9%
286,294
-6.9%
0.00%
Q3 2020$2,907,000
-1.7%
307,607
-12.0%
0.00%
-100.0%
Q2 2020$2,956,000
+46.8%
349,408
-14.3%
0.00%
Q1 2020$2,014,000
+1818.1%
407,921
+2690.7%
0.00%
Q4 2019$105,000
+262.1%
14,617
+443.0%
0.00%
Q3 2019$29,000
+3.6%
2,692
+17.2%
0.00%
Q2 2019$28,000
+40.0%
2,296
+15.8%
0.00%
Q1 2019$20,000
-23.1%
1,982
-18.9%
0.00%
Q4 2018$26,0002,4450.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Orbimed Advisors 8,466,783$5,758,0000.09%
HARBOR CAPITAL ADVISORS, INC. 226,731$154,0000.07%
Sio Capital Management, LLC 182,630$124,0000.04%
Virtu Financial LLC 71,475$49,0000.00%
Independence Bank of Kentucky 10,200$7,0000.00%
SANDERS MORRIS HARRIS LLC 15,000$10,0000.00%
Endurance Wealth Management, Inc. 1,500$12,0000.00%
Baker Brothers Advisors 451,478$307,0000.00%
Texas Yale Capital Corp. 20,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,900$54,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders